Santa Monica, CALIFORNIA2 Active Studies

Spinal Muscular Atrophy Clinical Trials in Santa Monica, CALIFORNIA

Find 2 actively recruiting spinal muscular atrophy clinical trials in Santa Monica, CALIFORNIA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
700
Enrolling

Recruiting Spinal Muscular Atrophy Studies in Santa Monica

About Spinal Muscular Atrophy Clinical Trials in Santa Monica

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.

There are currently 2 spinal muscular atrophy clinical trials recruiting participants in Santa Monica, CALIFORNIA. These studies are seeking a combined 700 participants. Research is being sponsored by Amgen, Merz North America, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Spinal Muscular Atrophy Clinical Trials in Santa Monica — FAQ

Are there spinal muscular atrophy clinical trials in Santa Monica?

Yes, there are 2 spinal muscular atrophy clinical trials currently recruiting in Santa Monica, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Santa Monica?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Santa Monica research site will contact you about next steps.

Are clinical trials in Santa Monica free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Santa Monica studies also compensate for your time and travel.

What spinal muscular atrophy treatments are being tested?

The 2 active trials in Santa Monica are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.

Data updated March 2, 2026 from ClinicalTrials.gov